• Comparative Gene Expression in the Mammalian Claustrum

  2026-10-07

  Fang and colleagues propose a cross-species framework for identifying conserved claustrum subdivisions by integrating gene expression, cytoarchitecture, and anatomical position. Their comparison across rats, shrews, tree shrews, marmosets, and macaques supports shared molecular and spatial organization while highlighting the limits of translating mouse-centered claustrum research across mammals.

• CCK-8 in ER Stress and PANoptosis Research

  2026-10-07

  This overview examines how Cell Counting Kit-8 supports interpretation of tunicamycin-induced endoplasmic reticulum stress and ZBP1-associated PANoptosis in macrophages and mouse spleen. It separates the assay’s viability-related contribution from mechanistic evidence, compares complementary readouts, and outlines limitations affecting causal interpretation and broader applicability.

• Tankyrase Inhibition and Hippo Signaling in HCC

  2026-10-06

  Jia et al. showed that the tankyrase inhibitors XAV-939 and G007-LK restrained hepatocellular carcinoma cell growth while reducing YAP activity and increasing the negative regulators AMOTL1 and AMOTL2. The study’s main contribution is a mechanistic link between tankyrase inhibition and Hippo-pathway control, although the evidence remains primarily pharmacological and cell-based.

• Liproxstatin-1 HCl in Ferroptosis Research

  2026-10-06

  A source-grounded overview of Liproxstatin-1 HCl, its reported role in ferroptosis research, links to mitochondrial calcium signaling and GPX4, and the evidence limits surrounding cellular and animal injury models.

• ARCA and the Next Frontier of Translational mRNA

  2026-10-05

  A source-grounded analysis of how Anti Reverse Cap Analog may shape synthetic mRNA translation, stability assessment, and translational strategy—without confusing product attributes with clinical evidence.

• From 25HC Biology to Translational Strategy

  2026-10-05

  A source-grounded analysis of how the CH25H–25HC–AMPKα–STAT6 axis reshapes macrophage biology, what the 2024 Immunity study establishes, and where translational researchers should draw boundaries when considering adjacent tools such as 6-OHDA hydrochloride.

• PPM-18, iNOS, and NF-κB: Evidence Overview

  2026-10-04

  PPM-18 is a chemically synthesized naphthoquinone derivative described as an inhibitor of NF-κB-regulated inducible nitric oxide synthase expression. This overview distinguishes supplier-reported findings from peer-reviewed evidence, compares the proposed mechanism with a 2023 oridonin bone-remodeling study, and defines the limits of applying macrophage or endotoxemia observations to osteoporosis, sepsis, or human inflammation.

• Zoledronic Acid: Mechanism and Research Evidence

  2026-10-03

  Zoledronic Acid is a nitrogen-containing bisphosphonate whose best-established pharmacology is inhibition of farnesyl pyrophosphate synthase in the mevalonate pathway. Evidence is strongest for osteoclast-mediated skeletal disease and multiple myeloma treatment research, while direct cancer-cell apoptosis remains model- and exposure-dependent.

• TCAIM, OGDH, and Mitochondrial Metabolic Control

  2026-10-02

  Wang and colleagues identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The study establishes mitochondrial proteostasis as a post-translational regulator of OGDH complex activity and carbohydrate metabolism in cells and mice.

• SU 5402 as a Causal Probe in HSV-1 Assays

  2026-10-01

  SU 5402 can do more than inhibit receptor tyrosine kinases: it can help researchers test how signaling state influences human neuronal assays. This guide connects its pharmacology with the validated hiPSC-derived sensory-neuron model of HSV-1 latency while emphasizing controls that distinguish pathway effects from toxicity.

• Melittin Workflows for GPCR and Cancer Biology

  2026-10-01

  Melittin is a versatile bioactive peptide for separating acute Gs/Gi signaling effects from longer-term viability, apoptosis, and migration phenotypes. This practical guide connects its use as a signal transduction modulator with the miR-18a/ALOXE3 findings in glioblastoma while clearly distinguishing established evidence from testable laboratory extensions.

• G007-LK: From Tankyrase Biology to Translation

  2026-09-30

  G007-LK offers a mechanistically informative route to interrogate tankyrase-dependent control of Wnt/β-catenin and Hippo signaling. This thought-leadership analysis connects APC-mutant colorectal cancer models with hepatocellular carcinoma evidence, while outlining practical validation strategies and translational limitations.

• Diminazene Aceturate Assay Workflows

  2026-09-30

  Diminazene Aceturate supports two distinct research applications: controlled trypanocidal testing and pathway-focused studies of ACE2-linked mitochondrial biology. This workflow explains how to prepare solutions, separate antiparasitic activity from host-cell effects, and build orthogonal readouts without overstating evidence from animal cardiomyopathy models.

• Lovastatin as a Tool for Causal Cell Biology

  2026-09-29

  Lovastatin is an HMG-CoA reductase inhibitor that connects mevalonate metabolism with proliferation, apoptosis, fibroblast behavior, and macrophage efferocytosis. This article presents a causal, assay-centered framework that also extracts experimental lessons from floral meristem research.

• Doxorubicin Workflows for Resistance Research

  2026-09-29

  Build reproducible Doxorubicin assays around DNA damage, apoptosis, and drug-efflux biology. This guide translates renal cell carcinoma resistance findings into practical dose-response, combination, and troubleshooting workflows for solid-tumor and hematologic models.

8476 records 1/566 page Next 12345 下5页 Last page